------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Two Japanese scientists said they discovered an antibody that, in laboratory test-tube experiments, kills AIDS-infected
    cells while preserving healthy cells.

Treebanked sentence:
--------------------
    Two Japanese scientists said 0 they discovered an antibody that , in laboratory test - tube experiments , *T*-1 kills
    AIDS - infected cells while *PRO*-2 preserving healthy cells .

Tree:
-----
    (TOP (S (NP-SBJ (CD Two)
                    (JJ Japanese)
                    (NNS scientists))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (PRP they))
                         (VP (VBD discovered)
                             (NP (NP (DT an)
                                     (NN antibody))
                                 (SBAR (WHNP-1 (IN that))
                                       (, ,)
                                       (S (PP-LOC (IN in)
                                                  (NP (NN laboratory)
                                                      (NML (NN test)
                                                           (HYPH -)
                                                           (NN tube))
                                                      (NNS experiments)))
                                          (, ,)
                                          (NP-SBJ-2 (-NONE- *T*-1))
                                          (VP (VBZ kills)
                                              (NP (ADJP (NNP AIDS)
                                                        (HYPH -)
                                                        (VBN infected))
                                                  (NNS cells))
                                              (SBAR-TMP (IN while)
                                                        (S (NP-SBJ (-NONE- *PRO*-2))
                                                           (VP (VBG preserving)
                                                               (NP (JJ healthy)
                                                                   (NNS cells)))))))))))))
            (. .)))

Leaves:
-------
    0   Two
           coref: IDENT        21    0-2    Two Japanese scientists
           name:  CARDINAL           0-0    Two
    1   Japanese
           name:  NORP               1-1    Japanese
    2   scientists
    3   said
           sense: say-v.1
           prop:  say.01
            v          * -> 3:0,  said
            ARG0       * -> 0:1,  Two Japanese scientists
            ARG1       * -> 4:1,  0 they discovered an antibody that , in laboratory test - tube experiments , *T*-1
                                  kills AIDS - infected cells while *PRO*-2 preserving healthy cells
           coref: IDENT        30    3-3    said
    4   0
    5   they
           coref: IDENT        21    5-5    they
    6   discovered
           sense: discover-v.1
           prop:  discover.01
            v          * -> 6:0,  discovered
            ARG0       * -> 5:1,  they
            ARG1       * -> 7:2,  an antibody that , in laboratory test - tube experiments , *T*-1 kills AIDS - infected
                                  cells while *PRO*-2 preserving healthy cells
           coref: IDENT        22    6-6    discovered
    7   an
           coref: IDENT        16    7-28   an antibody that , in laboratory test - tube experiments , *T*-1 kills
                                            AIDS - infected cells while *PRO*-2 preserving healthy cells
    8   antibody
    9   that
    10  ,
    11  in
    12  laboratory
           coref: IDENT        28    12-16  laboratory test - tube experiments
    13  test
    14  -
    15  tube
    16  experiments
           sense: experiment-n.1
           prop:  experiment.01
            n          * -> 16:0, experiments
            ARGM-LOC   * -> 12:0, laboratory
            ARG2       * -> 13:1, test - tube
    17  ,
    18  *T*-1
    19  kills
           sense: kill-v.1
           prop:  kill.01
            v          * -> 19:0, kills
            ARG0       * -> 18:0, *T*-1 -> 9:1, that
            ARGM-LOC   * -> 11:1, in laboratory test - tube experiments
            ARG1       * -> 20:2, AIDS - infected cells
            ARGM-TMP   * -> 24:1, while *PRO*-2 preserving healthy cells
            LINK-SLC   * -> 7:1,  an antibody
                       * -> 18:0, *T*-1 -> 9:1, that
    20  AIDS
           coref: IDENT        20    20-22  AIDS - infected
    21  -
    22  infected
    23  cells
           sense: cell-n.1
    24  while
    25  *PRO*-2
    26  preserving
           sense: preserve-v.2
           prop:  preserve.01
            v          * -> 26:0, preserving
            ARG0       * -> 25:0, *PRO*-2 -> 18:0, *T*-1 -> 9:1, that
            ARG1       * -> 27:1, healthy cells
            LINK-SLC   * -> 7:1,  an antibody
                       * -> 25:0, *PRO*-2 -> 18:0, *T*-1 -> 9:1, that
    27  healthy
    28  cells
           sense: cell-n.1
    29  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    If further experiments are successful, the work would represent a major advance in research on acquired immune
    deficiency syndrome.

Treebanked sentence:
--------------------
    If further experiments are successful , the work would represent a major advance in research on acquired immune
    deficiency syndrome .

Tree:
-----
    (TOP (S (SBAR-ADV (IN If)
                      (S (NP-SBJ (JJ further)
                                 (NNS experiments))
                         (VP (VBP are)
                             (ADJP-PRD (JJ successful)))))
            (, ,)
            (NP-SBJ (DT the)
                    (NN work))
            (VP (MD would)
                (VP (VB represent)
                    (NP (NP (DT a)
                            (JJ major)
                            (NN advance))
                        (PP (IN in)
                            (NP (NP (NN research))
                                (PP (IN on)
                                    (NP (NML (VBN acquired)
                                             (JJ immune)
                                             (NN deficiency))
                                        (NN syndrome))))))))
            (. .)))

Leaves:
-------
    0   If
    1   further
           coref: IDENT        40    1-2    further experiments
    2   experiments
           sense: experiment-n.1
           prop:  experiment.01
            n          * -> 2:0,  experiments
            ARGM-EXT   * -> 1:0,  further
    3   are
           sense: be-v.1
           prop:  be.01
            v          * -> 3:0,  are
            ARG1       * -> 1:1,  further experiments
            ARG2       * -> 4:1,  successful
    4   successful
    5   ,
    6   the
           coref: IDENT        40    6-7    the work
    7   work
    8   would
    9   represent
           sense: represent-v.1
           prop:  represent.01
            v          * -> 9:0,  represent
            ARGM-ADV   * -> 0:1,  If further experiments are successful
            ARG0       * -> 6:1,  the work
            ARGM-MOD   * -> 8:0,  would
            ARG1       * -> 10:2, a major advance in research on acquired immune deficiency syndrome
    10  a
    11  major
    12  advance
           sense: advance-n.2
           prop:  advance.01
            n          * -> 12:0, advance
            ARGM-EXT   * -> 11:0, major
            ARG1       * -> 13:1, in research on acquired immune deficiency syndrome
    13  in
    14  research
           sense: research-n.1
    15  on
    16  acquired
           prop:  acquire.01
            v          * -> 16:0, acquired
            ARG1       * -> 17:0, immune
                         -> 18:0, deficiency
                         -> 19:0, syndrome
           coref: IDENT        20    16-19  acquired immune deficiency syndrome
    17  immune
    18  deficiency
    19  syndrome
    20  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The drug AZT, the only treatment currently on the market, claims only to help stop the spread of AIDS, not to cure it.

Treebanked sentence:
--------------------
    The drug AZT , the only treatment currently on the market , claims *PRO*-1 only to help *PRO* stop the spread of AIDS ,
    not to cure it .

Tree:
-----
    (TOP (S (NP-SBJ-1 (NP (DT The)
                          (NN drug)
                          (NNP AZT))
                      (, ,)
                      (NP (NP (DT the)
                              (JJ only)
                              (NN treatment))
                          (RRC (ADVP-TMP (RB currently))
                               (PP (IN on)
                                   (NP (DT the)
                                       (NN market)))))
                      (, ,))
            (VP (VBZ claims)
                (S (NP-SBJ (-NONE- *PRO*-1))
                   (ADVP (RB only))
                   (VP (VP (TO to)
                           (VP (VB help)
                               (S (NP-SBJ (-NONE- *PRO*))
                                  (VP (VB stop)
                                      (NP (NP (DT the)
                                              (NN spread))
                                          (PP (IN of)
                                              (NP (NNP AIDS))))))))
                       (, ,)
                       (RB not)
                       (VP (TO to)
                           (VP (VB cure)
                               (NP (PRP it)))))))
            (. .)))

Leaves:
-------
    0   The
           coref: IDENT        35    0-11   The drug AZT , the only treatment currently on the market ,
           coref: APPOS HEAD   23    0-2    The drug AZT
    1   drug
    2   AZT
           name:  PRODUCT            2-2    AZT
    3   ,
    4   the
           coref: APPOS ATTRIB 23    4-10   the only treatment currently on the market
    5   only
    6   treatment
           sense: treatment-n.1
    7   currently
    8   on
    9   the
    10  market
           sense: market-n.1
    11  ,
    12  claims
           sense: claim-v.1
           prop:  claim.01
            v          * -> 12:0, claims
            ARG0       * -> 0:2,  The drug AZT , the only treatment currently on the market ,
            ARG1       * -> 13:2, *PRO*-1 only to help *PRO* stop the spread of AIDS , not to cure it
    13  *PRO*-1
    14  only
    15  to
    16  help
           sense: help-v.1
           prop:  help.01
            v          * -> 16:0, help
            ARG0       * -> 13:0, *PRO*-1 -> 0:2, The drug AZT , the only treatment currently on the market ,
            ARG1       * -> 17:2, *PRO* stop the spread of AIDS
    17  *PRO*
    18  stop
           sense: stop-v.2
           prop:  stop.01
            v          * -> 18:0, stop
            ARG0       * -> 17:0, *PRO*
            ARG1       * -> 19:2, the spread of AIDS
            LINK-PCR   * -> 0:2,  The drug AZT , the only treatment currently on the market ,
                       * -> 17:0, *PRO*
    19  the
    20  spread
           sense: spread-n.1
           prop:  spread.02
            n          * -> 20:0, spread
            ARG1       * -> 21:1, of AIDS
    21  of
    22  AIDS
           coref: IDENT        20    22-22  AIDS
    23  ,
    24  not
    25  to
    26  cure
           sense: cure-v.1
           prop:  cure.01
            v          * -> 26:0, cure
            ARG3       * -> 0:2,  The drug AZT , the only treatment currently on the market ,
            ARGM-NEG   * -> 24:0, not
            ARG2       * -> 27:1, it
    27  it
           coref: IDENT        20    27-27  it
    28  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    But several analysts and Japanese scientists familiar with the study, which was announced at a conference in Nagoya
    yesterday, expressed skepticism over the significance of the results.

Treebanked sentence:
--------------------
    But several analysts and Japanese scientists familiar with the study , which *T*-2 was announced *-1 at a conference in
    Nagoya yesterday , expressed skepticism over the significance of the results .

Tree:
-----
    (TOP (S (CC But)
            (NP-SBJ (NP (NP (JJ several)
                            (NNS analysts))
                        (CC and)
                        (NP (JJ Japanese)
                            (NNS scientists)))
                    (ADJP (JJ familiar)
                          (PP (IN with)
                              (NP (NP (DT the)
                                      (NN study))
                                  (, ,)
                                  (SBAR (WHNP-2 (WDT which))
                                        (S (NP-SBJ-1 (-NONE- *T*-2))
                                           (VP (VBD was)
                                               (VP (VBN announced)
                                                   (NP (-NONE- *-1))
                                                   (PP-LOC (IN at)
                                                           (NP (NP (DT a)
                                                                   (NN conference))
                                                               (PP-LOC (IN in)
                                                                       (NP (NNP Nagoya)))))
                                                   (NP-TMP (NN yesterday))))))
                                  (, ,)))))
            (VP (VBD expressed)
                (NP (NN skepticism))
                (PP-CLR (IN over)
                        (NP (NP (DT the)
                                (NN significance))
                            (PP (IN of)
                                (NP (DT the)
                                    (NNS results))))))
            (. .)))

Leaves:
-------
    0   But
    1   several
    2   analysts
           sense: analyst-n.1
    3   and
    4   Japanese
           name:  NORP               4-4    Japanese
    5   scientists
    6   familiar
    7   with
    8   the
    9   study
           sense: study-n.3
           prop:  study.01
            n          * -> 9:0,  study
            ARGM-ADJ   * -> 11:2, which *T*-2 was announced *-1 at a conference in Nagoya yesterday
    10  ,
    11  which
    12  *T*-2
    13  was
    14  announced
           sense: announce-v.1
           prop:  announce.01
            v          * -> 14:0, announced
            ARG1       * -> 15:0, *-1 -> 12:0, *T*-2 -> 11:1, which
            ARGM-LOC   * -> 16:1, at a conference in Nagoya
            ARGM-TMP   * -> 21:1, yesterday
            LINK-SLC   * -> 8:1,  the study
                       * -> 15:0, *-1 -> 12:0, *T*-2 -> 11:1, which
    15  *-1
    16  at
    17  a
    18  conference
           sense: conference-n.1
    19  in
    20  Nagoya
           name:  GPE                20-20  Nagoya
    21  yesterday
           sense: yesterday-n.1
           coref: IDENT        24    21-21  yesterday
           name:  DATE               21-21  yesterday
    22  ,
    23  expressed
           sense: express-v.1
           prop:  express.01
            v          * -> 23:0, expressed
            ARG0       * -> 1:3,  several analysts and Japanese scientists familiar with the study , which *T*-2 was
                                  announced *-1 at a conference in Nagoya yesterday ,
            ARG1       * -> 24:1, skepticism
            ARGM-ADV   * -> 25:1, over the significance of the results
    24  skepticism
    25  over
    26  the
    27  significance
           sense: significance-n.1
    28  of
    29  the
           coref: IDENT        32    29-30  the results
    30  results
           sense: result-n.3
    31  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    And the researchers themselves acknowledged they still must do much more work before they can say whether the treatment
    would actually cure humans.

Treebanked sentence:
--------------------
    And the researchers themselves acknowledged 0 they still must do much more work before they can say whether the
    treatment would actually cure humans .

Tree:
-----
    (TOP (S (CC And)
            (NP-SBJ (NP (DT the)
                        (NNS researchers))
                    (NP (PRP themselves)))
            (VP (VBD acknowledged)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (PRP they))
                         (ADVP (RB still))
                         (VP (MD must)
                             (VP (VB do)
                                 (NP (ADJP (RB much)
                                           (JJR more))
                                     (NN work))
                                 (SBAR-TMP (IN before)
                                           (S (NP-SBJ (PRP they))
                                              (VP (MD can)
                                                  (VP (VB say)
                                                      (SBAR (IN whether)
                                                            (S (NP-SBJ (DT the)
                                                                       (NN treatment))
                                                               (VP (MD would)
                                                                   (ADVP (RB actually))
                                                                   (VP (VB cure)
                                                                       (NP (NNS humans)))))))))))))))
            (. .)))

Leaves:
-------
    0   And
    1   the
           coref: IDENT        21    1-3    the researchers themselves
    2   researchers
    3   themselves
    4   acknowledged
           sense: acknowledge-v.1
           prop:  acknowledge.01
            v          * -> 4:0,  acknowledged
            ARGM-DIS   * -> 0:0,  And
            ARG0       * -> 1:2,  the researchers themselves
            ARG1       * -> 5:1,  0 they still must do much more work before they can say whether the treatment would
                                  actually cure humans
    5   0
    6   they
           coref: IDENT        21    6-6    they
    7   still
    8   must
    9   do
           sense: do-v.1
           prop:  do.02
            v          * -> 9:0,  do
            ARG0       * -> 6:1,  they
            ARGM-ADV   * -> 7:1,  still
            ARGM-MOD   * -> 8:0,  must
            ARG1       * -> 10:2, much more work
            ARGM-TMP   * -> 13:1, before they can say whether the treatment would actually cure humans
    10  much
    11  more
    12  work
    13  before
    14  they
           coref: IDENT        21    14-14  they
    15  can
    16  say
           sense: say-v.6
           prop:  say.01
            v          * -> 16:0, say
            ARG0       * -> 14:1, they
            ARGM-MOD   * -> 15:0, can
            ARG1       * -> 17:1, whether the treatment would actually cure humans
    17  whether
    18  the
    19  treatment
           sense: treatment-n.1
    20  would
    21  actually
    22  cure
           sense: cure-v.1
           prop:  cure.01
            v          * -> 22:0, cure
            ARG3       * -> 18:1, the treatment
            ARGM-MOD   * -> 20:0, would
            ARGM-ADV   * -> 21:1, actually
            ARG1       * -> 23:1, humans
    23  humans
    24  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Shin Yonehara, a research scientist at the Tokyo Metropolitan Institute of Medical Science, said the antibody he
    discovered works by recognizing an antigen called a Fas-antigen, which is characteristic of an infected cell.

Treebanked sentence:
--------------------
    Shin Yonehara , a research scientist at the Tokyo Metropolitan Institute of Medical Science , said 0 the antibody 0 he
    discovered *T*-2 works by *PRO* recognizing an antigen called * *PRO*-3 a Fas - antigen , which *T*-1 is characteristic
    of an infected cell .

Tree:
-----
    (TOP (S (NP-SBJ (NP (NNP Shin)
                        (NNP Yonehara))
                    (, ,)
                    (NP (NP (DT a)
                            (NN research)
                            (NN scientist))
                        (PP-LOC (IN at)
                                (NP (NP (DT the)
                                        (NNP Tokyo)
                                        (NNP Metropolitan)
                                        (NNP Institute))
                                    (PP (IN of)
                                        (NP (NNP Medical)
                                            (NNP Science))))))
                    (, ,))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (NP (DT the)
                                     (NN antibody))
                                 (SBAR (WHNP-2 (-NONE- 0))
                                       (S (NP-SBJ (PRP he))
                                          (VP (VBD discovered)
                                              (NP (-NONE- *T*-2))))))
                         (VP (VBZ works)
                             (PP-MNR (IN by)
                                     (S-NOM (NP-SBJ (-NONE- *PRO*))
                                            (VP (VBG recognizing)
                                                (NP (NP (NP (DT an)
                                                            (NN antigen))
                                                        (VP (VBN called)
                                                            (NP-3 (-NONE- *))
                                                            (S-CLR (NP-SBJ (-NONE- *PRO*-3))
                                                                   (NP-PRD (DT a)
                                                                           (NNP Fas)
                                                                           (HYPH -)
                                                                           (NNP antigen)))))
                                                    (, ,)
                                                    (SBAR (WHNP-1 (WDT which))
                                                          (S (NP-SBJ (-NONE- *T*-1))
                                                             (VP (VBZ is)
                                                                 (ADJP-PRD (JJ characteristic)
                                                                           (PP (IN of)
                                                                               (NP (DT an)
                                                                                   (JJ infected)
                                                                                   (NN cell)))))))))))))))
            (. .)))

Leaves:
-------
    0   Shin
           coref: IDENT        18    0-14   Shin Yonehara , a research scientist at the Tokyo Metropolitan Institute
                                            of Medical Science ,
           coref: APPOS HEAD   25    0-1    Shin Yonehara
           name:  PERSON             0-1    Shin Yonehara
    1   Yonehara
    2   ,
    3   a
           coref: APPOS ATTRIB 25    3-13   a research scientist at the Tokyo Metropolitan Institute of Medical
                                            Science
    4   research
    5   scientist
    6   at
    7   the
           name:  ORG                7-13   the Tokyo Metropolitan Institute of Medical Science
    8   Tokyo
    9   Metropolitan
    10  Institute
    11  of
    12  Medical
    13  Science
    14  ,
    15  said
           sense: say-v.1
           prop:  say.01
            v          * -> 15:0, said
            ARG0       * -> 0:2,  Shin Yonehara , a research scientist at the Tokyo Metropolitan Institute of Medical
                                  Science ,
            ARG1       * -> 16:1, 0 the antibody 0 he discovered *T*-2 works by *PRO* recognizing an antigen called *
                                  *PRO*-3 a Fas - antigen , which *T*-1 is characteristic of an infected cell
    16  0
    17  the
           coref: IDENT        16    17-22  the antibody 0 he discovered *T*-2
    18  antibody
    19  0
    20  he
           coref: IDENT        18    20-20  he
    21  discovered
           sense: discover-v.1
           prop:  discover.01
            v          * -> 21:0, discovered
            ARG1       * -> 22:0, *T*-2 -> 19:0, 0
            ARG0       * -> 20:1, he
            LINK-PCR   * -> 17:1, the antibody
                       * -> 19:0, 0
                       * -> 22:0, *T*-2 -> 19:0, 0
    22  *T*-2
    23  works
           sense: work-v.2
           prop:  work.01
            v          * -> 23:0, works
            ARG0       * -> 17:2, the antibody 0 he discovered *T*-2
            ARGM-MNR   * -> 24:1, by *PRO* recognizing an antigen called * *PRO*-3 a Fas - antigen , which *T*-1 is
                                  characteristic of an infected cell
    24  by
    25  *PRO*
    26  recognizing
           sense: recognize-v.1
           prop:  recognize.01
            v          * -> 26:0, recognizing
            ARG0       * -> 25:0, *PRO*
            ARG1       * -> 27:3, an antigen called * *PRO*-3 a Fas - antigen , which *T*-1 is characteristic of an
                                  infected cell
            LINK-PCR   * -> 17:2, the antibody 0 he discovered *T*-2
                       * -> 25:0, *PRO*
    27  an
    28  antigen
    29  called
           sense: call-v.5
           prop:  call.01
            v          * -> 29:0, called
            ARG1       * -> 30:0, *
            ARG2       * -> 32:1, a Fas - antigen
            LINK-PCR   * -> 27:1, an antigen
                       * -> 30:0, *
    30  *
    31  *PRO*-3
    32  a
    33  Fas
    34  -
    35  antigen
    36  ,
    37  which
    38  *T*-1
    39  is
           sense: be-v.1
           prop:  be.01
            v          * -> 39:0, is
            ARG1       * -> 38:0, *T*-1 -> 37:1, which
            ARG2       * -> 40:1, characteristic of an infected cell
            LINK-SLC   * -> 27:2, an antigen called * *PRO*-3 a Fas - antigen
                       * -> 38:0, *T*-1 -> 37:1, which
    40  characteristic
    41  of
    42  an
           coref: IDENT        26    42-44  an infected cell
    43  infected
    44  cell
           sense: cell-n.1
    45  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The antibody then kills the cell.

Treebanked sentence:
--------------------
    The antibody then kills the cell .

Tree:
-----
    (TOP (S (NP-SBJ (DT The)
                    (NN antibody))
            (ADVP-TMP (RB then))
            (VP (VBZ kills)
                (NP (DT the)
                    (NN cell)))
            (. .)))

Leaves:
-------
    0   The
           coref: IDENT        16    0-1    The antibody
    1   antibody
    2   then
    3   kills
           sense: kill-v.1
           prop:  kill.01
            v          * -> 3:0,  kills
            ARG0       * -> 0:1,  The antibody
            ARGM-TMP   * -> 2:1,  then
            ARG1       * -> 4:1,  the cell
    4   the
           coref: IDENT        26    4-5    the cell
    5   cell
           sense: cell-n.1
    6   .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Dr. Yonehara and his partner, Nobuyuki Kobayashi of Yamaguchi University, said their experiments showed that the
    antibody wiped out an average of 60 % of AIDS-infected cells within three days.

Treebanked sentence:
--------------------
    Dr. Yonehara and his partner , Nobuyuki Kobayashi of Yamaguchi University , said 0 their experiments showed that the
    antibody wiped out an average of 60 % of AIDS - infected cells within three days .

Tree:
-----
    (TOP (S (NP-SBJ (NP (NNP Dr.)
                        (NNP Yonehara))
                    (CC and)
                    (NP (NP (PRP$ his)
                            (NN partner))
                        (, ,)
                        (NP (NP (NNP Nobuyuki)
                                (NNP Kobayashi))
                            (PP (IN of)
                                (NP (NNP Yamaguchi)
                                    (NNP University))))
                        (, ,)))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (PRP$ their)
                                 (NNS experiments))
                         (VP (VBD showed)
                             (SBAR (IN that)
                                   (S (NP-SBJ (DT the)
                                              (NN antibody))
                                      (VP (VBD wiped)
                                          (PRT (RP out))
                                          (NP (NP (DT an)
                                                  (NN average))
                                              (PP (IN of)
                                                  (NP (NP (CD 60)
                                                          (NN %))
                                                      (PP (IN of)
                                                          (NP (ADJP (NNP AIDS)
                                                                    (HYPH -)
                                                                    (VBN infected))
                                                              (NNS cells))))))
                                          (PP-TMP (IN within)
                                                  (NP (CD three)
                                                      (NNS days))))))))))
            (. .)))

Leaves:
-------
    0   Dr.
           coref: IDENT        18    0-1    Dr. Yonehara
           coref: IDENT        21    0-11   Dr. Yonehara and his partner , Nobuyuki Kobayashi of Yamaguchi University
                                            ,
    1   Yonehara
           name:  PERSON             1-1    Yonehara
    2   and
    3   his
           coref: IDENT        18    3-3    his
           coref: IDENT        13    3-11   his partner , Nobuyuki Kobayashi of Yamaguchi University ,
           coref: APPOS ATTRIB 27    3-4    his partner
    4   partner
           sense: partner-n.2
    5   ,
    6   Nobuyuki
           coref: APPOS HEAD   27    6-10   Nobuyuki Kobayashi of Yamaguchi University
           name:  PERSON             6-7    Nobuyuki Kobayashi
    7   Kobayashi
    8   of
    9   Yamaguchi
           name:  ORG                9-10   Yamaguchi University
    10  University
    11  ,
    12  said
           sense: say-v.1
           prop:  say.01
            v          * -> 12:0, said
            ARG0       * -> 0:2,  Dr. Yonehara and his partner , Nobuyuki Kobayashi of Yamaguchi University ,
            ARG1       * -> 13:1, 0 their experiments showed that the antibody wiped out an average of 60 % of AIDS -
                                  infected cells within three days
    13  0
    14  their
           coref: IDENT        28    14-15  their experiments
           coref: IDENT        21    14-14  their
    15  experiments
           sense: experiment-n.1
           prop:  experiment.01
            n          * -> 15:0, experiments
            ARG0       * -> 14:0, their
    16  showed
           sense: show-v.1
           prop:  show.01
            v          * -> 16:0, showed
            ARG0       * -> 14:1, their experiments
            ARG1       * -> 17:1, that the antibody wiped out an average of 60 % of AIDS - infected cells within three
                                  days
    17  that
    18  the
           coref: IDENT        16    18-19  the antibody
    19  antibody
    20  wiped
           sense: wipe-v.2
           prop:  wipe.02
            v          * -> 20:0, wiped
                         -> 21:1, out
            ARG0       * -> 18:1, the antibody
            ARG1       * -> 22:2, an average of 60 % of AIDS - infected cells
            ARGM-TMP   * -> 32:1, within three days
    21  out
    22  an
    23  average
           sense: average-n.1
    24  of
    25  60
           name:  PERCENT            25-26  60 %
    26  %
    27  of
    28  AIDS
           coref: IDENT        20    28-30  AIDS - infected
    29  -
    30  infected
    31  cells
           sense: cell-n.1
    32  within
    33  three
           name:  DATE               33-34  three days
    34  days
           sense: day-n.2
    35  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    In some of the experiments, it killed almost all the infected cells, the researchers said.

Treebanked sentence:
--------------------
    In some of the experiments , it killed almost all the infected cells , the researchers said 0 *T*-1 .

Tree:
-----
    (TOP (S (S-TPC-1 (PP-LOC (IN In)
                             (NP (NP (DT some))
                                 (PP (IN of)
                                     (NP (DT the)
                                         (NNS experiments)))))
                     (, ,)
                     (NP-SBJ (PRP it))
                     (VP (VBD killed)
                         (NP (QP (RB almost)
                                 (PDT all))
                             (DT the)
                             (JJ infected)
                             (NNS cells))))
            (, ,)
            (NP-SBJ (DT the)
                    (NNS researchers))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (-NONE- *T*-1))))
            (. .)))

Leaves:
-------
    0   In
    1   some
    2   of
    3   the
           coref: IDENT        28    3-4    the experiments
    4   experiments
           sense: experiment-n.1
           prop:  experiment.01
            n          * -> 4:0,  experiments
    5   ,
    6   it
           coref: IDENT        16    6-6    it
    7   killed
           sense: kill-v.1
           prop:  kill.01
            v          * -> 7:0,  killed
            ARGM-LOC   * -> 0:1,  In some of the experiments
            ARG0       * -> 6:1,  it
            ARG1       * -> 8:2,  almost all the infected cells
    8   almost
    9   all
    10  the
    11  infected
    12  cells
           sense: cell-n.1
    13  ,
    14  the
           coref: IDENT        21    14-15  the researchers
    15  researchers
    16  said
           sense: say-v.1
           prop:  say.01
            v          * -> 16:0, said
            ARG1       * -> 18:0, *T*-1 -> 0:2, In some of the experiments , it killed almost all the infected cells
            ARG0       * -> 14:1, the researchers
    17  0
    18  *T*-1
    19  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Meanwhile, fewer than 10 % of the healthy cells were killed.

Treebanked sentence:
--------------------
    Meanwhile , fewer than 10 % of the healthy cells were killed *-1 .

Tree:
-----
    (TOP (S (ADVP (RB Meanwhile))
            (, ,)
            (NP-SBJ-1 (NP (QP (JJR fewer)
                              (IN than)
                              (CD 10))
                          (NN %))
                      (PP (IN of)
                          (NP (DT the)
                              (JJ healthy)
                              (NNS cells))))
            (VP (VBD were)
                (VP (VBN killed)
                    (NP (-NONE- *-1))))
            (. .)))

Leaves:
-------
    0   Meanwhile
    1   ,
    2   fewer
           name:  PERCENT            2-5    fewer than 10 %
    3   than
    4   10
    5   %
    6   of
    7   the
    8   healthy
    9   cells
           sense: cell-n.1
    10  were
    11  killed
           sense: kill-v.1
           prop:  kill.01
            v          * -> 11:0, killed
            ARGM-DIS   * -> 0:1,  Meanwhile
            ARG1       * -> 12:0, *-1 -> 2:3, fewer than 10 % of the healthy cells
    12  *-1
    13  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The two said they must still do more laboratory tests, then experiment on animals.

Treebanked sentence:
--------------------
    The two said 0 they must still do more laboratory tests , then experiment on animals .

Tree:
-----
    (TOP (S (NP-SBJ (DT The)
                    (CD two))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (PRP they))
                         (VP (MD must)
                             (ADVP (RB still))
                             (VP (VP (VB do)
                                     (NP (JJR more)
                                         (NN laboratory)
                                         (NNS tests)))
                                 (, ,)
                                 (RB then)
                                 (VP (NN experiment)
                                     (PP-CLR (IN on)
                                             (NP (NNS animals)))))))))
            (. .)))

Leaves:
-------
    0   The
           coref: IDENT        21    0-1    The two
    1   two
           name:  CARDINAL           1-1    two
    2   said
           sense: say-v.1
           prop:  say.01
            v          * -> 2:0,  said
            ARG0       * -> 0:1,  The two
            ARG1       * -> 3:1,  0 they must still do more laboratory tests , then experiment on animals
    3   0
    4   they
           coref: IDENT        21    4-4    they
    5   must
    6   still
    7   do
           sense: do-v.1
           prop:  do.02
            v          * -> 7:0,  do
            ARG0       * -> 4:1,  they
            ARGM-MOD   * -> 5:0,  must
            ARGM-ADV   * -> 6:1,  still
            ARG1       * -> 8:1,  more laboratory tests
    8   more
    9   laboratory
    10  tests
           sense: test-n.1
    11  ,
    12  then
    13  experiment
           sense: experiment-n.1
    14  on
    15  animals
    16  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    They said they hoped to conduct tests on human patients in the U.S. by late next year.

Treebanked sentence:
--------------------
    They said 0 they hoped *PRO*-1 to conduct tests on human patients in the U.S. by late next year .

Tree:
-----
    (TOP (S (NP-SBJ (PRP They))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ-1 (PRP they))
                         (VP (VBD hoped)
                             (S (NP-SBJ (-NONE- *PRO*-1))
                                (VP (TO to)
                                    (VP (VB conduct)
                                        (NP (NNS tests))
                                        (PP-CLR (IN on)
                                                (NP (NP (JJ human)
                                                        (NNS patients))
                                                    (PP-LOC (IN in)
                                                            (NP (DT the)
                                                                (NNP U.S.)))))
                                        (PP-TMP (IN by)
                                                (NP (ADVP (RB late))
                                                    (JJ next)
                                                    (NN year))))))))))
            (. .)))

Leaves:
-------
    0   They
           coref: IDENT        21    0-0    They
    1   said
           sense: say-v.1
           prop:  say.01
            v          * -> 1:0,  said
            ARG0       * -> 0:1,  They
            ARG1       * -> 2:1,  0 they hoped *PRO*-1 to conduct tests on human patients in the U.S. by late next year
    2   0
    3   they
           coref: IDENT        21    3-3    they
    4   hoped
           sense: hope-v.1
           prop:  hope.01
            v          * -> 4:0,  hoped
            ARG0       * -> 3:1,  they
            ARG1       * -> 5:2,  *PRO*-1 to conduct tests on human patients in the U.S. by late next year
    5   *PRO*-1
    6   to
    7   conduct
           sense: conduct-v.2
           prop:  conduct.01
            v          * -> 7:0,  conduct
            ARG0       * -> 5:0,  *PRO*-1 -> 3:1, they
            ARG1       * -> 8:1,  tests
            ARGM-LOC   * -> 9:1,  on human patients in the U.S.
            ARGM-TMP   * -> 15:1, by late next year
    8   tests
           sense: test-n.1
    9   on
    10  human
    11  patients
    12  in
    13  the
    14  U.S.
           name:  GPE                14-14  U.S.
    15  by
    16  late
           name:  DATE               16-18  late next year
    17  next
    18  year
    19  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Japan does n't have enough AIDS patients to do significant experimentation in that country, they said.

Treebanked sentence:
--------------------
    Japan does n't have enough AIDS patients *PRO*-1 to do significant experimentation in that country , they said 0 *T*-2 .

Tree:
-----
    (TOP (S (S-TPC-2 (NP-SBJ-1 (NNP Japan))
                     (VP (VBZ does)
                         (RB n't)
                         (VP (VB have)
                             (NP (JJ enough)
                                 (NNP AIDS)
                                 (NNS patients)
                                 (S (NP-SBJ (-NONE- *PRO*-1))
                                    (VP (TO to)
                                        (VP (VB do)
                                            (NP (JJ significant)
                                                (NN experimentation))
                                            (PP-LOC (IN in)
                                                    (NP (DT that)
                                                        (NN country))))))))))
            (, ,)
            (NP-SBJ (PRP they))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (-NONE- *T*-2))))
            (. .)))

Leaves:
-------
    0   Japan
           coref: IDENT        29    0-0    Japan
           name:  GPE                0-0    Japan
    1   does
    2   n't
    3   have
           sense: have-v.5
           prop:  have.03
            v          * -> 3:0,  have
            ARG0       * -> 0:1,  Japan
            ARGM-NEG   * -> 2:0,  n't
            ARG1       * -> 4:1,  enough AIDS patients *PRO*-1 to do significant experimentation in that country
    4   enough
    5   AIDS
           coref: IDENT        20    5-5    AIDS
    6   patients
    7   *PRO*-1
    8   to
    9   do
           sense: do-v.1
           prop:  do.02
            v          * -> 9:0,  do
            ARG0       * -> 7:0,  *PRO*-1 -> 0:1, Japan
            ARG1       * -> 10:1, significant experimentation
            ARGM-LOC   * -> 12:1, in that country
    10  significant
    11  experimentation
    12  in
    13  that
           coref: IDENT        29    13-14  that country
    14  country
           sense: country-n.3
    15  ,
    16  they
           coref: IDENT        21    16-16  they
    17  said
           sense: say-v.1
           prop:  say.01
            v          * -> 17:0, said
            ARG0       * -> 16:1, they
            ARG1       * -> 18:1, 0 *T*-2
    18  0
    19  *T*-2
    20  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The announcement got wide exposure in the Japanese media, and even moved some pharmaceutical stocks yesterday.

Treebanked sentence:
--------------------
    The announcement got wide exposure in the Japanese media , and even moved some pharmaceutical stocks yesterday .

Tree:
-----
    (TOP (S (NP-SBJ (DT The)
                    (NN announcement))
            (VP (VP (VBD got)
                    (NP (JJ wide)
                        (NN exposure))
                    (PP-LOC (IN in)
                            (NP (DT the)
                                (JJ Japanese)
                                (NNS media))))
                (, ,)
                (CC and)
                (ADVP (RB even))
                (VP (VBD moved)
                    (NP (DT some)
                        (NN pharmaceutical)
                        (NNS stocks))
                    (NP-TMP (NN yesterday))))
            (. .)))

Leaves:
-------
    0   The
           coref: IDENT        30    0-1    The announcement
    1   announcement
           sense: announcement-n.1
           prop:  announcement.01
            n          * -> 1:0,  announcement
    2   got
           sense: get-v.1
           prop:  get.01
            v          * -> 2:0,  got
            ARG0       * -> 0:1,  The announcement
            ARG1       * -> 3:1,  wide exposure
            ARGM-LOC   * -> 5:1,  in the Japanese media
    3   wide
    4   exposure
           sense: exposure-n.7
           prop:  exposure.01
            n          * -> 4:0,  exposure
            ARGM-EXT   * -> 3:0,  wide
    5   in
    6   the
    7   Japanese
           name:  NORP               7-7    Japanese
    8   media
           sense: medium-n.8
    9   ,
    10  and
    11  even
    12  moved
           sense: move-v.1
           prop:  move.01
            v          * -> 12:0, moved
            ARG0       * -> 0:1,  The announcement
            ARGM-ADV   * -> 11:1, even
            ARG1       * -> 13:1, some pharmaceutical stocks
            ARGM-TMP   * -> 16:1, yesterday
    13  some
    14  pharmaceutical
    15  stocks
           sense: stock-n.1
    16  yesterday
           sense: yesterday-n.1
           coref: IDENT        24    16-16  yesterday
           name:  DATE               16-16  yesterday
    17  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    But Takashi Kitamura, director of the biology department at Japan's National Institute of Health and secretary of the
    government's AIDS-research center, said, `` I'm not so optimistic of its future use in therapeutic methods. ''

Treebanked sentence:
--------------------
    But Takashi Kitamura , director of the biology department at Japan 's National Institute of Health and secretary of the
    government 's AIDS - research center , said , `` I 'm not so optimistic of its future use in therapeutic methods . ''

Tree:
-----
    (TOP (S (CC But)
            (NP-SBJ (NP (NNP Takashi)
                        (NNP Kitamura))
                    (, ,)
                    (NP (NP (NP (NN director))
                            (PP (IN of)
                                (NP (NP (DT the)
                                        (NN biology)
                                        (NN department))
                                    (PP-LOC (IN at)
                                            (NP (NP (NP (NNP Japan)
                                                        (POS 's))
                                                    (NNP National)
                                                    (NNP Institute))
                                                (PP (IN of)
                                                    (NP (NNP Health))))))))
                        (CC and)
                        (NP (NP (NN secretary))
                            (PP (IN of)
                                (NP (NP (DT the)
                                        (NN government)
                                        (POS 's))
                                    (NML (NNP AIDS)
                                         (HYPH -)
                                         (NN research))
                                    (NN center)))))
                    (, ,))
            (VP (VBD said)
                (, ,)
                (`` ``)
                (S (NP-SBJ (PRP I))
                   (VP (VBP 'm)
                       (RB not)
                       (ADJP-PRD (RB so)
                                 (JJ optimistic)
                                 (PP (IN of)
                                     (NP (NP (PRP$ its)
                                             (JJ future)
                                             (NN use))
                                         (PP-LOC (IN in)
                                                 (NP (JJ therapeutic)
                                                     (NNS methods)))))))))
            (. .)
            ('' '')))

Leaves:
-------
    0   But
    1   Takashi
           coref: IDENT        14    1-26   Takashi Kitamura , director of the biology department at Japan 's National
                                            Institute of Health and secretary of the government 's AIDS - research
                                            center ,
           coref: APPOS HEAD   31    1-2    Takashi Kitamura
           name:  PERSON             1-2    Takashi Kitamura
    2   Kitamura
    3   ,
    4   director
           sense: director-n.1
           coref: APPOS ATTRIB 31    4-25   director of the biology department at Japan 's National Institute of
                                            Health and secretary of the government 's AIDS - research center
    5   of
    6   the
    7   biology
    8   department
           sense: department-n.1
    9   at
    10  Japan
           coref: IDENT        29    10-11  Japan 's
           name:  GPE                10-10  Japan
    11  's
    12  National
        !  name:  ORG                12-15  National Institute of Health
    13  Institute
    14  of
    15  Health
    16  and
    17  secretary
           sense: secretary-n.1
    18  of
    19  the
           coref: IDENT        29    19-21  the government 's
    20  government
           sense: government-n.1
    21  's
    22  AIDS
           coref: IDENT        20    22-24  AIDS - research
    23  -
    24  research
    25  center
           sense: center-n.2
    26  ,
    27  said
           sense: say-v.1
           prop:  say.01
            v          * -> 27:0, said
            ARGM-DIS   * -> 0:0,  But
            ARG0       * -> 1:2,  Takashi Kitamura , director of the biology department at Japan 's National Institute
                                  of Health and secretary of the government 's AIDS - research center ,
            ARG1       * -> 30:2, I 'm not so optimistic of its future use in therapeutic methods
    28  ,
    29  ``
    30  I
           coref: IDENT        14    30-30  I
    31  'm
           sense: be-v.1
           prop:  be.01
            v          * -> 31:0, 'm
            ARG1       * -> 30:1, I
            ARG2       * -> 33:1, so optimistic of its future use in therapeutic methods
            ARGM-NEG   * -> 32:0, not
    32  not
    33  so
    34  optimistic
    35  of
    36  its
           coref: IDENT        16    36-36  its
    37  future
    38  use
           sense: use-n.2
           prop:  use.01
            n          * -> 38:0, use
            ARG1       * -> 36:0, its
            ARGM-TMP   * -> 37:0, future
            ARG2       * -> 39:1, in therapeutic methods
    39  in
    40  therapeutic
    41  methods
    42  .
    43  ''


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    He said some infected cells may not have the relevant antigen and so would n't be killed even after exposure to the
    antibody.

Treebanked sentence:
--------------------
    He said 0 some infected cells may not have the relevant antigen and so would n't be killed *-1 even after exposure to
    the antibody .

Tree:
-----
    (TOP (S (NP-SBJ (PRP He))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ-1 (DT some)
                                   (JJ infected)
                                   (NNS cells))
                         (VP (VP (MD may)
                                 (RB not)
                                 (VP (VB have)
                                     (NP (DT the)
                                         (JJ relevant)
                                         (NN antigen))))
                             (CC and)
                             (ADVP (RB so))
                             (VP (MD would)
                                 (RB n't)
                                 (VP (VB be)
                                     (VP (VBN killed)
                                         (NP (-NONE- *-1))
                                         (PP-TMP (ADVP (RB even))
                                                 (IN after)
                                                 (NP (NP (NN exposure))
                                                     (PP (IN to)
                                                         (NP (DT the)
                                                             (NN antibody))))))))))))
            (. .)))

Leaves:
-------
    0   He
           coref: IDENT        14    0-0    He
    1   said
           sense: say-v.1
           prop:  say.01
            v          * -> 1:0,  said
            ARG0       * -> 0:1,  He
            ARG1       * -> 2:1,  0 some infected cells may not have the relevant antigen and so would n't be killed *-1
                                  even after exposure to the antibody
    2   0
    3   some
    4   infected
    5   cells
           sense: cell-n.1
    6   may
    7   not
    8   have
           sense: have-v.2
           prop:  have.03
            v          * -> 8:0,  have
            ARG0       * -> 3:1,  some infected cells
            ARGM-MOD   * -> 6:0,  may
            ARGM-NEG   * -> 7:0,  not
            ARG1       * -> 9:1,  the relevant antigen
    9   the
    10  relevant
    11  antigen
    12  and
    13  so
    14  would
    15  n't
    16  be
    17  killed
           sense: kill-v.1
           prop:  kill.01
            v          * -> 17:0, killed
            ARG1       * -> 18:0, *-1 -> 3:1, some infected cells
            ARGM-DIS   * -> 13:1, so
            ARGM-MOD   * -> 14:0, would
            ARGM-NEG   * -> 15:0, n't
            ARGM-TMP   * -> 19:2, even after exposure to the antibody
    18  *-1
    19  even
    20  after
    21  exposure
           sense: exposure-n.2
           prop:  exposure.01
            n          * -> 21:0, exposure
            ARG2       * -> 22:1, to the antibody
    22  to
    23  the
           coref: IDENT        16    23-24  the antibody
    24  antibody
    25  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    `` The results seem to be very premature, '' said Mitsuru Miyata, editor of Nikkei Biotechnology, a leading Japanese
    industry newsletter.

Treebanked sentence:
--------------------
    `` The results seem *-1 to be very premature , '' said *T*-2 Mitsuru Miyata , editor of Nikkei Biotechnology , a leading
    Japanese industry newsletter .

Tree:
-----
    (TOP (SINV (`` ``)
               (S-TPC-2 (NP-SBJ-1 (DT The)
                                  (NNS results))
                        (VP (VBP seem)
                            (S (NP-SBJ (-NONE- *-1))
                               (VP (TO to)
                                   (VP (VB be)
                                       (ADJP-PRD (RB very)
                                                 (JJ premature)))))))
               (, ,)
               ('' '')
               (VP (VBD said)
                   (S (-NONE- *T*-2)))
               (NP-SBJ (NP (NNP Mitsuru)
                           (NNP Miyata))
                       (, ,)
                       (NP (NP (NN editor))
                           (PP (IN of)
                               (NP (NP (NNP Nikkei)
                                       (NNP Biotechnology))
                                   (, ,)
                                   (NP (DT a)
                                       (VBG leading)
                                       (JJ Japanese)
                                       (NN industry)
                                       (NN newsletter))))))
               (. .)))

Leaves:
-------
    0   ``
    1   The
           coref: IDENT        32    1-2    The results
    2   results
           sense: result-n.3
    3   seem
           sense: seem-v.1
           prop:  seem.01
            v          * -> 3:0,  seem
            ARG1       * -> 1:1,  The results
                         -> 4:2,  *-1 to be very premature
    4   *-1
    5   to
    6   be
           sense: be-v.1
           prop:  be.01
            v          * -> 6:0,  be
            ARG1       * -> 4:0,  *-1 -> 1:1, The results
            ARG2       * -> 7:1,  very premature
    7   very
    8   premature
    9   ,
    10  ''
    11  said
           sense: say-v.1
           prop:  say.01
            v          * -> 11:0, said
            ARG1       * -> 12:0, *T*-2 -> 1:2, The results seem *-1 to be very premature
            ARG0       * -> 13:2, Mitsuru Miyata , editor of Nikkei Biotechnology , a leading Japanese industry
                                  newsletter
    12  *T*-2
    13  Mitsuru
           coref: APPOS HEAD   33    13-14  Mitsuru Miyata
           name:  PERSON             13-14  Mitsuru Miyata
    14  Miyata
    15  ,
    16  editor
           coref: APPOS ATTRIB 33    16-25  editor of Nikkei Biotechnology , a leading Japanese industry newsletter
    17  of
    18  Nikkei
           coref: APPOS HEAD   34    18-19  Nikkei Biotechnology
           name:  ORG                18-19  Nikkei Biotechnology
    19  Biotechnology
    20  ,
    21  a
           coref: APPOS ATTRIB 34    21-25  a leading Japanese industry newsletter
    22  leading
           sense: lead-v.2
           prop:  lead.01
            v          * -> 22:0, leading
            ARG0       * -> 23:0, Japanese
                         -> 24:0, industry
                         -> 25:0, newsletter
    23  Japanese
           name:  NORP               23-23  Japanese
    24  industry
    25  newsletter
    26  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Dr. Kobayashi responded that he thought the antibody could potentially kill all infected cells.

Treebanked sentence:
--------------------
    Dr. Kobayashi responded that he thought 0 the antibody could potentially kill all infected cells .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Dr.)
                    (NNP Kobayashi))
            (VP (VBD responded)
                (SBAR (IN that)
                      (S (NP-SBJ (PRP he))
                         (VP (VBD thought)
                             (SBAR (-NONE- 0)
                                   (S (NP-SBJ (DT the)
                                              (NN antibody))
                                      (VP (MD could)
                                          (ADVP (RB potentially))
                                          (VP (VB kill)
                                              (NP (DT all)
                                                  (JJ infected)
                                                  (NNS cells))))))))))
            (. .)))

Leaves:
-------
    0   Dr.
           coref: IDENT        13    0-1    Dr. Kobayashi
    1   Kobayashi
           name:  PERSON             1-1    Kobayashi
    2   responded
           sense: respond-v.2
           prop:  respond.01
            v          * -> 2:0,  responded
            ARG0       * -> 0:1,  Dr. Kobayashi
            ARG2       * -> 3:1,  that he thought 0 the antibody could potentially kill all infected cells
    3   that
    4   he
           coref: IDENT        13    4-4    he
    5   thought
           sense: think-v.1
           prop:  think.01
            v          * -> 5:0,  thought
            ARG0       * -> 4:1,  he
            ARG1       * -> 6:1,  0 the antibody could potentially kill all infected cells
    6   0
    7   the
           coref: IDENT        16    7-8    the antibody
    8   antibody
    9   could
    10  potentially
    11  kill
           sense: kill-v.1
           prop:  kill.01
            v          * -> 11:0, kill
            ARG0       * -> 7:1,  the antibody
            ARGM-MOD   * -> 9:0,  could
            ARGM-ADV   * -> 10:1, potentially
            ARG1       * -> 12:1, all infected cells
    12  all
    13  infected
    14  cells
           sense: cell-n.1
    15  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    But he and Dr. Yonehara said there were still several uncertainties, particularly regarding possible side effects.

Treebanked sentence:
--------------------
    But he and Dr. Yonehara said 0 there were still several uncertainties , particularly regarding possible side effects .

Tree:
-----
    (TOP (S (CC But)
            (NP-SBJ (NP (PRP he))
                    (CC and)
                    (NP (NNP Dr.)
                        (NNP Yonehara)))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (EX there))
                         (VP (VBD were)
                             (ADVP (RB still))
                             (NP-PRD (NP (JJ several)
                                         (NNS uncertainties))
                                     (, ,)
                                     (RRC (ADVP (RB particularly))
                                          (PP (VBG regarding)
                                              (NP (JJ possible)
                                                  (NN side)
                                                  (NNS effects)))))))))
            (. .)))

Leaves:
-------
    0   But
    1   he
           coref: IDENT        21    1-4    he and Dr. Yonehara
           coref: IDENT        13    1-1    he
    2   and
    3   Dr.
           coref: IDENT        18    3-4    Dr. Yonehara
    4   Yonehara
           name:  PERSON             4-4    Yonehara
    5   said
           sense: say-v.1
           prop:  say.01
            v          * -> 5:0,  said
            ARGM-DIS   * -> 0:0,  But
            ARG0       * -> 1:2,  he and Dr. Yonehara
            ARG1       * -> 6:1,  0 there were still several uncertainties , particularly regarding possible side
                                  effects
    6   0
    7   there
    8   were
           sense: be-v.3
           prop:  be.02
            v          * -> 8:0,  were
            ARG1       * -> 10:2, several uncertainties , particularly regarding possible side effects
            ARGM-TMP   * -> 9:1,  still
    9   still
    10  several
    11  uncertainties
    12  ,
    13  particularly
    14  regarding
           sense: regard-v.3
    15  possible
    16  side
           sense: side-n.9
    17  effects
           sense: effect-n.1
    18  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    `` Our antibody specifically killed infected cells at a very low dose, but it can also kill other cells, '' said Dr.
    Yonehara.

Treebanked sentence:
--------------------
    `` Our antibody specifically killed infected cells at a very low dose , but it can also kill other cells , '' said *T*-1
    Dr. Yonehara .

Tree:
-----
    (TOP (SINV (`` ``)
               (S-TPC-1 (S (NP-SBJ (PRP$ Our)
                                   (NN antibody))
                           (ADVP (RB specifically))
                           (VP (VBD killed)
                               (NP (JJ infected)
                                   (NNS cells))
                               (PP-MNR (IN at)
                                       (NP (DT a)
                                           (ADJP (RB very)
                                                 (JJ low))
                                           (NN dose)))))
                        (, ,)
                        (CC but)
                        (S (NP-SBJ (PRP it))
                           (VP (MD can)
                               (ADVP (RB also))
                               (VP (VB kill)
                                   (NP (JJ other)
                                       (NNS cells))))))
               (, ,)
               ('' '')
               (VP (VBD said)
                   (S (-NONE- *T*-1)))
               (NP-SBJ (NNP Dr.)
                       (NNP Yonehara))
               (. .)))

Leaves:
-------
    0   ``
    1   Our
           coref: IDENT        16    1-2    Our antibody
           coref: IDENT        21    1-1    Our
    2   antibody
    3   specifically
    4   killed
           sense: kill-v.1
           prop:  kill.01
            v          * -> 4:0,  killed
            ARG0       * -> 1:1,  Our antibody
            ARGM-ADV   * -> 3:1,  specifically
            ARG1       * -> 5:1,  infected cells
            ARGM-MNR   * -> 7:1,  at a very low dose
    5   infected
    6   cells
           sense: cell-n.1
    7   at
    8   a
    9   very
    10  low
    11  dose
    12  ,
    13  but
    14  it
           coref: IDENT        16    14-14  it
    15  can
    16  also
    17  kill
           sense: kill-v.1
           prop:  kill.01
            v          * -> 17:0, kill
            ARG0       * -> 14:1, it
            ARGM-MOD   * -> 15:0, can
            ARGM-DIS   * -> 16:1, also
            ARG1       * -> 18:1, other cells
    18  other
    19  cells
           sense: cell-n.1
    20  ,
    21  ''
    22  said
           sense: say-v.1
           prop:  say.01
            v          * -> 22:0, said
            ARG1       * -> 23:0, *T*-1 -> 1:3, Our antibody specifically killed infected cells at a very low dose , but
                                                it can also kill other cells
            ARG0       * -> 24:1, Dr. Yonehara
    23  *T*-1
    24  Dr.
           coref: IDENT        18    24-25  Dr. Yonehara
    25  Yonehara
           name:  PERSON             25-25  Yonehara
    26  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    `` We do n't know the effect of our antibody on the human body. ''

Treebanked sentence:
--------------------
    `` We do n't know the effect of our antibody on the human body . ''

Tree:
-----
    (TOP (S (`` ``)
            (NP-SBJ (PRP We))
            (VP (VBP do)
                (RB n't)
                (VP (VB know)
                    (NP (NP (DT the)
                            (NN effect))
                        (PP (IN of)
                            (NP (PRP$ our)
                                (NN antibody)))
                        (PP (IN on)
                            (NP (DT the)
                                (JJ human)
                                (NN body))))))
            (. .)
            ('' '')))

Leaves:
-------
    0   ``
    1   We
           coref: IDENT        21    1-1    We
    2   do
    3   n't
    4   know
           sense: know-v.1
           prop:  know.01
            v          * -> 4:0,  know
            ARG0       * -> 1:1,  We
            ARGM-NEG   * -> 3:0,  n't
            ARG1       * -> 5:2,  the effect of our antibody on the human body
    5   the
    6   effect
           sense: effect-n.1
    7   of
    8   our
           coref: IDENT        16    8-9    our antibody
           coref: IDENT        21    8-8    our
    9   antibody
    10  on
    11  the
    12  human
    13  body
           sense: body-n.2
    14  .
    15  ''


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    AIDS is n't considered a widespread problem in Japan--the government reports about 1,000 known carriers of the
    virus--but many companies have poured substantial resources into research in recent years, hoping to cash in on a
    possible cure.

Treebanked sentence:
--------------------
    AIDS is n't considered *-1 a widespread problem in Japan -- the government reports about 1,000 known carriers of the
    virus -- but many companies have poured substantial resources into research in recent years , *PRO*-2 hoping *PRO*-3 to
    cash in on a possible cure .

Tree:
-----
    (TOP (S (S (NP-SBJ-1 (NNP AIDS))
               (VP (VBZ is)
                   (RB n't)
                   (VP (VBN considered)
                       (S (NP-SBJ (-NONE- *-1))
                          (NP-PRD (NP (DT a)
                                      (JJ widespread)
                                      (NN problem))
                                  (PP-LOC (IN in)
                                          (NP (NNP Japan))))))))
            (: --)
            (S (NP-SBJ (DT the)
                       (NN government))
               (VP (VBZ reports)
                   (NP (NP (QP (IN about)
                               (CD 1,000))
                           (VBN known)
                           (NNS carriers))
                       (PP (IN of)
                           (NP (DT the)
                               (NN virus))))))
            (: --)
            (CC but)
            (S (NP-SBJ-2 (JJ many)
                         (NNS companies))
               (VP (VBP have)
                   (VP (VBN poured)
                       (NP (JJ substantial)
                           (NNS resources))
                       (PP-CLR (IN into)
                               (NP (NN research)))
                       (PP-TMP (IN in)
                               (NP (JJ recent)
                                   (NNS years)))
                       (, ,)
                       (S-ADV (NP-SBJ-3 (-NONE- *PRO*-2))
                              (VP (VBG hoping)
                                  (S (NP-SBJ (-NONE- *PRO*-3))
                                     (VP (TO to)
                                         (VP (VB cash)
                                             (PRT (RP in))
                                             (PP-CLR (IN on)
                                                     (NP (DT a)
                                                         (JJ possible)
                                                         (NN cure)))))))))))
            (. .)))

Leaves:
-------
    0   AIDS
           coref: IDENT        20    0-0    AIDS
    1   is
    2   n't
    3   considered
           sense: consider-v.1
           prop:  consider.01
            v          * -> 3:0,  considered
            ARGM-NEG   * -> 2:0,  n't
            ARG1       * -> 4:2,  *-1 a widespread problem in Japan
    4   *-1
    5   a
    6   widespread
    7   problem
           sense: problem-n.1
    8   in
    9   Japan
           coref: IDENT        29    9-9    Japan
           name:  GPE                9-9    Japan
    10  --
    11  the
           coref: IDENT        29    11-12  the government
    12  government
           sense: government-n.1
    13  reports
           sense: report-v.1
           prop:  report.01
            v          * -> 13:0, reports
            ARG0       * -> 11:1, the government
            ARG1       * -> 14:3, about 1,000 known carriers of the virus
    14  about
           name:  CARDINAL           14-15  about 1,000
    15  1,000
    16  known
           prop:  know.01
            v          * -> 16:0, known
            ARG1       * -> 17:0, carriers
    17  carriers
           sense: carrier-n.10
    18  of
    19  the
           coref: IDENT        20    19-20  the virus
    20  virus
    21  --
    22  but
    23  many
    24  companies
           sense: company-n.1
    25  have
    26  poured
           sense: pour-v.3
           prop:  pour.01
            v          * -> 26:0, poured
            ARG0       * -> 23:1, many companies
            ARG1       * -> 27:1, substantial resources
            ARG3       * -> 29:1, into research
            ARGM-TMP   * -> 31:1, in recent years
            ARGM-ADV   * -> 35:2, *PRO*-2 hoping *PRO*-3 to cash in on a possible cure
    27  substantial
    28  resources
           sense: resource-n.1
    29  into
    30  research
           sense: research-n.1
    31  in
    32  recent
           name:  DATE               32-33  recent years
    33  years
    34  ,
    35  *PRO*-2
    36  hoping
           sense: hope-v.1
           prop:  hope.01
            v          * -> 36:0, hoping
            ARG0       * -> 35:0, *PRO*-2 -> 23:1, many companies
            ARG1       * -> 37:2, *PRO*-3 to cash in on a possible cure
    37  *PRO*-3
    38  to
    39  cash
           sense: cash-v.2
           prop:  cash.03
            v          * -> 39:0, cash
                         -> 40:1, in
            ARG0       * -> 37:0, *PRO*-3 -> 35:0, *PRO*-2 -> 23:1, many companies
            ARG1       * -> 41:1, on a possible cure
    40  in
    41  on
    42  a
    43  possible
    44  cure
           sense: cure-n.1
           prop:  cure.01
            n          * -> 44:0, cure
            ARGM-ADJ   * -> 43:0, possible
    45  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Dr. Kitamura said about 35 projects are currently under way in Japan, and that Japanese researchers in the past year
    have made available three possible cures to American researchers for clinical tests.

Treebanked sentence:
--------------------
    Dr. Kitamura said 0 about 35 projects are currently under way in Japan , and that Japanese researchers in the past year
    have made available *ICH*-1 *ICH*-2 three possible cures to American researchers for clinical tests .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Dr.)
                    (NNP Kitamura))
            (VP (VBD said)
                (SBAR (SBAR (-NONE- 0)
                            (S (NP-SBJ (QP (IN about)
                                           (CD 35))
                                       (NNS projects))
                               (VP (VBP are)
                                   (ADVP-TMP (RB currently))
                                   (PP-PRD (IN under)
                                           (NP (NN way)))
                                   (PP-LOC (IN in)
                                           (NP (NNP Japan))))))
                      (, ,)
                      (CC and)
                      (SBAR (IN that)
                            (S (NP-SBJ (NP (JJ Japanese)
                                           (NNS researchers))
                                       (PP-TMP (IN in)
                                               (NP (DT the)
                                                   (JJ past)
                                                   (NN year))))
                               (VP (VBP have)
                                   (VP (VBN made)
                                       (S (ADJP-PRD (JJ available)
                                                    (PP (-NONE- *ICH*-1))
                                                    (PP (-NONE- *ICH*-2)))
                                          (NP-SBJ (CD three)
                                                  (JJ possible)
                                                  (NNS cures))
                                          (PP-1 (IN to)
                                                (NP (JJ American)
                                                    (NNS researchers)))
                                          (PP-2 (IN for)
                                                (NP (JJ clinical)
                                                    (NNS tests))))))))))
            (. .)))

Leaves:
-------
    0   Dr.
           coref: IDENT        14    0-1    Dr. Kitamura
    1   Kitamura
           name:  PERSON             1-1    Kitamura
    2   said
           sense: say-v.1
           prop:  say.01
            v          * -> 2:0,  said
            ARG0       * -> 0:1,  Dr. Kitamura
            ARG1       * -> 3:2,  0 about 35 projects are currently under way in Japan , and that Japanese researchers
                                  in the past year have made available *ICH*-1 *ICH*-2 three possible cures to American
                                  researchers for clinical tests
                         -> 33:1, for clinical tests
                       * -> 26:0, *ICH*-2 -> 33:1, for clinical tests
    3   0
    4   about
           name:  CARDINAL           4-5    about 35
    5   35
    6   projects
           sense: project-n.1
    7   are
           sense: be-v.1
           prop:  be.01
            v          * -> 7:0,  are
            ARG1       * -> 4:2,  about 35 projects
            ARG2       * -> 9:1,  under way
            ARGM-LOC   * -> 11:1, in Japan
            ARGM-TMP   * -> 8:1,  currently
    8   currently
    9   under
    10  way
           sense: way-n.4
    11  in
    12  Japan
           coref: IDENT        29    12-12  Japan
           name:  GPE                12-12  Japan
    13  ,
    14  and
    15  that
    16  Japanese
           name:  NORP               16-16  Japanese
    17  researchers
    18  in
    19  the
           name:  DATE               19-21  the past year
    20  past
    21  year
    22  have
    23  made
           sense: make-v.3
           prop:  make.02
            v          * -> 23:0, made
            ARG0       * -> 16:2, Japanese researchers in the past year
            ARG1       * -> 24:2, available *ICH*-1 *ICH*-2 three possible cures to American researchers for clinical
                                  tests
                         -> 30:1, to American researchers
                       * -> 25:0, *ICH*-1 -> 30:1, to American researchers
    24  available
    25  *ICH*-1
    26  *ICH*-2
    27  three
           name:  CARDINAL           27-27  three
    28  possible
    29  cures
           sense: cure-n.1
           prop:  cure.01
            n          * -> 29:0, cures
            ARGM-ADJ   * -> 28:0, possible
    30  to
    31  American
           name:  NORP               31-31  American
    32  researchers
    33  for
    34  clinical
    35  tests
           sense: test-n.1
    36  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    He said that when scientists from the two countries meet again in January in New Orleans, the Japanese will present at
    least three more drugs for human testing.

Treebanked sentence:
--------------------
    He said that when scientists from the two countries meet again in January in New Orleans *T*-1 , the Japanese will
    present at least three more drugs for human testing .

Tree:
-----
    (TOP (S (NP-SBJ (PRP He))
            (VP (VBD said)
                (SBAR (IN that)
                      (S (SBAR-TMP (WHADVP-1 (WRB when))
                                   (S (NP-SBJ (NP (NNS scientists))
                                              (PP (IN from)
                                                  (NP (DT the)
                                                      (CD two)
                                                      (NNS countries))))
                                      (VP (VBP meet)
                                          (ADVP (RB again))
                                          (PP-TMP (IN in)
                                                  (NP (NNP January)))
                                          (PP-LOC (IN in)
                                                  (NP (NNP New)
                                                      (NNP Orleans)))
                                          (ADVP-TMP (-NONE- *T*-1)))))
                         (, ,)
                         (NP-SBJ (DT the)
                                 (NNP Japanese))
                         (VP (MD will)
                             (VP (VB present)
                                 (NP (ADJP (QP (ADVP (RB at)
                                                     (RBS least))
                                               (CD three))
                                           (JJR more))
                                     (NNS drugs))
                                 (PP-CLR (IN for)
                                         (NP (JJ human)
                                             (NN testing))))))))
            (. .)))

Leaves:
-------
    0   He
           coref: IDENT        14    0-0    He
    1   said
           sense: say-v.1
           prop:  say.01
            v          * -> 1:0,  said
            ARG0       * -> 0:1,  He
            ARG1       * -> 2:1,  that when scientists from the two countries meet again in January in New Orleans *T*-1
                                  , the Japanese will present at least three more drugs for human testing
    2   that
    3   when
    4   scientists
    5   from
    6   the
    7   two
           name:  CARDINAL           7-7    two
    8   countries
           sense: country-n.3
    9   meet
           sense: meet-v.2
           prop:  meet.03
            v          * -> 9:0,  meet
            ARGM-TMP   * -> 16:0, *T*-1 -> 3:1, when
            ARG0       * -> 4:2,  scientists from the two countries
            ARGM-TMP   * -> 10:1, again
            ARGM-TMP   * -> 11:1, in January
            ARGM-LOC   * -> 13:1, in New Orleans
    10  again
    11  in
    12  January
           name:  DATE               12-12  January
    13  in
    14  New
           name:  GPE                14-15  New Orleans
    15  Orleans
    16  *T*-1
    17  ,
    18  the
    19  Japanese
           name:  NORP               19-19  Japanese
    20  will
    21  present
           sense: present-v.3
           prop:  present.01
            v          * -> 21:0, present
            ARGM-TMP   * -> 3:2,  when scientists from the two countries meet again in January in New Orleans *T*-1
            ARG0       * -> 18:1, the Japanese
            ARGM-MOD   * -> 20:0, will
            ARG1       * -> 22:4, at least three more drugs
            ARGM-PNC   * -> 27:1, for human testing
    22  at
           name:  CARDINAL           22-24  at least three
    23  least
    24  three
    25  more
    26  drugs
           sense: drug-n.1
    27  for
    28  human
    29  testing
           sense: test-n.4
    30  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    AZT is the world's only prescription medicine approved for treating the disease.

Treebanked sentence:
--------------------
    AZT is the world 's only prescription medicine approved * for *PRO* treating the disease .

Tree:
-----
    (TOP (S (NP-SBJ (NNP AZT))
            (VP (VBZ is)
                (NP-PRD (NP (NP (DT the)
                                (NN world)
                                (POS 's))
                            (JJ only)
                            (NN prescription)
                            (NN medicine))
                        (VP (VBN approved)
                            (NP (-NONE- *))
                            (PP-CLR (IN for)
                                    (S-NOM (NP-SBJ (-NONE- *PRO*))
                                           (VP (VBG treating)
                                               (NP (DT the)
                                                   (NN disease))))))))
            (. .)))

Leaves:
-------
    0   AZT
           coref: IDENT        35    0-0    AZT
           name:  PRODUCT            0-0    AZT
    1   is
           sense: be-v.2
           prop:  be.01
            v          * -> 1:0,  is
            ARG1       * -> 0:1,  AZT
            ARG2       * -> 2:3,  the world 's only prescription medicine approved * for *PRO* treating the disease
    2   the
    3   world
           sense: world-n.1
    4   's
    5   only
    6   prescription
    7   medicine
           sense: medicine-n.1
    8   approved
           sense: approve-v.1
           prop:  approve.01
            v          * -> 8:0,  approved
            ARG1       * -> 9:0,  *
            ARG2       * -> 10:1, for *PRO* treating the disease
            LINK-PCR   * -> 2:2,  the world 's only prescription medicine
                       * -> 9:0,  *
    9   *
    10  for
    11  *PRO*
    12  treating
           sense: treat-v.4
           prop:  treat.03
            v          * -> 12:0, treating
            ARG3       * -> 11:0, *PRO*
            ARG2       * -> 13:1, the disease
            LINK-PCR   * -> 2:2,  the world 's only prescription medicine
                       * -> 11:0, *PRO*
    13  the
           coref: IDENT        20    13-14  the disease
    14  disease
    15  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Wellcome PLC, a major British pharmaceutical maker, sells the drug under the name Retrovir.

Treebanked sentence:
--------------------
    Wellcome PLC , a major British pharmaceutical maker , sells the drug under the name Retrovir .

Tree:
-----
    (TOP (S (NP-SBJ (NP (NNP Wellcome)
                        (NNP PLC))
                    (, ,)
                    (NP (DT a)
                        (JJ major)
                        (JJ British)
                        (NN pharmaceutical)
                        (NN maker))
                    (, ,))
            (VP (VBZ sells)
                (NP (DT the)
                    (NN drug))
                (PP-MNR (IN under)
                        (NP (NP (DT the)
                                (NN name))
                            (NP (NNP Retrovir)))))
            (. .)))

Leaves:
-------
    0   Wellcome
           coref: APPOS HEAD   36    0-1    Wellcome PLC
           coref: IDENT        39    0-8    Wellcome PLC , a major British pharmaceutical maker ,
           name:  ORG                0-1    Wellcome PLC
    1   PLC
    2   ,
    3   a
           coref: APPOS ATTRIB 36    3-7    a major British pharmaceutical maker
    4   major
    5   British
           name:  NORP               5-5    British
    6   pharmaceutical
    7   maker
           sense: maker-n.1
    8   ,
    9   sells
           sense: sell-v.1
           prop:  sell.01
            v          * -> 9:0,  sells
            ARG0       * -> 0:2,  Wellcome PLC , a major British pharmaceutical maker ,
            ARG1       * -> 10:1, the drug
            ARGM-MNR   * -> 12:1, under the name Retrovir
    10  the
           coref: IDENT        35    10-11  the drug
    11  drug
           sense: drug-n.1
    12  under
    13  the
           coref: IDENT        38    13-15  the name Retrovir
    14  name
           sense: name-n.1
    15  Retrovir
           name:  PRODUCT            15-15  Retrovir
    16  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    A Wellcome spokesman declined to comment on the discovery of the antibody in Japan.

Treebanked sentence:
--------------------
    A Wellcome spokesman declined *PRO*-1 to comment on the discovery of the antibody in Japan .

Tree:
-----
    (TOP (S (NP-SBJ-1 (DT A)
                      (NNP Wellcome)
                      (NN spokesman))
            (VP (VBD declined)
                (S (NP-SBJ (-NONE- *PRO*-1))
                   (VP (TO to)
                       (VP (VB comment)
                           (PP-CLR (IN on)
                                   (NP (NP (DT the)
                                           (NN discovery))
                                       (PP (IN of)
                                           (NP (DT the)
                                               (NN antibody)))
                                       (PP-LOC (IN in)
                                               (NP (NNP Japan)))))))))
            (. .)))

Leaves:
-------
    0   A
    1   Wellcome
           coref: IDENT        39    1-1    Wellcome
           name:  ORG                1-1    Wellcome
    2   spokesman
    3   declined
           sense: decline-v.2
           prop:  decline.02
            v          * -> 3:0,  declined
            ARG0       * -> 0:1,  A Wellcome spokesman
            ARG1       * -> 4:2,  *PRO*-1 to comment on the discovery of the antibody in Japan
    4   *PRO*-1
    5   to
    6   comment
           sense: comment-v.1
           prop:  comment.01
            v          * -> 6:0,  comment
            ARG0       * -> 4:0,  *PRO*-1 -> 0:1, A Wellcome spokesman
            ARG1       * -> 7:1,  on the discovery of the antibody in Japan
    7   on
    8   the
           coref: IDENT        22    8-14   the discovery of the antibody in Japan
    9   discovery
           sense: discovery-n.1
           prop:  discovery.01
            n          * -> 9:0,  discovery
            ARG1       * -> 10:1, of the antibody
            ARGM-LOC   * -> 13:1, in Japan
    10  of
    11  the
           coref: IDENT        16    11-12  the antibody
    12  antibody
    13  in
    14  Japan
           coref: IDENT        29    14-14  Japan
           name:  GPE                14-14  Japan
    15  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    But Andrew Porter, a drug-industry analyst at Nikko Securities Co. in London, said if the product were to be
    successfully developed it would represent `` a potential threat to the long-term viability of Retrovir.

Treebanked sentence:
--------------------
    But Andrew Porter , a drug - industry analyst at Nikko Securities Co. in London , said 0 if the product were *-2 to be
    successfully developed *-1 it would represent `` a potential threat to the long - term viability of Retrovir .

Tree:
-----
    (TOP (S (CC But)
            (NP-SBJ (NP (NNP Andrew)
                        (NNP Porter))
                    (, ,)
                    (NP (NP (DT a)
                            (NML (NN drug)
                                 (HYPH -)
                                 (NN industry))
                            (NN analyst))
                        (PP-LOC (IN at)
                                (NP (NP (NNP Nikko)
                                        (NNPS Securities)
                                        (NNP Co.))
                                    (PP-LOC (IN in)
                                            (NP (NNP London))))))
                    (, ,))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (SBAR-ADV (IN if)
                                   (S (NP-SBJ-2 (DT the)
                                                (NN product))
                                      (VP (VBD were)
                                          (S (NP-SBJ-1 (-NONE- *-2))
                                             (VP (TO to)
                                                 (VP (VB be)
                                                     (ADVP-MNR (RB successfully))
                                                     (VP (VBN developed)
                                                         (NP (-NONE- *-1)))))))))
                         (NP-SBJ (PRP it))
                         (VP (MD would)
                             (VP (VB represent)
                                 (`` ``)
                                 (NP (NP (DT a)
                                         (JJ potential)
                                         (NN threat))
                                     (PP (IN to)
                                         (NP (NP (DT the)
                                                 (NML (JJ long)
                                                      (HYPH -)
                                                      (NN term))
                                                 (NN viability))
                                             (PP (IN of)
                                                 (NP (NNP Retrovir)))))))))))
            (. .)))

Leaves:
-------
    0   But
    1   Andrew
           coref: APPOS HEAD   37    1-2    Andrew Porter
           name:  PERSON             1-2    Andrew Porter
    2   Porter
    3   ,
    4   a
           coref: APPOS ATTRIB 37    4-14   a drug - industry analyst at Nikko Securities Co. in London
    5   drug
    6   -
    7   industry
    8   analyst
           sense: analyst-n.1
    9   at
    10  Nikko
           name:  ORG                10-12  Nikko Securities Co.
    11  Securities
    12  Co.
    13  in
    14  London
           name:  GPE                14-14  London
    15  ,
    16  said
           sense: say-v.1
           prop:  say.01
            v          * -> 16:0, said
            ARGM-DIS   * -> 0:0,  But
            ARG0       * -> 1:2,  Andrew Porter , a drug - industry analyst at Nikko Securities Co. in London ,
            ARG1       * -> 17:1, 0 if the product were *-2 to be successfully developed *-1 it would represent `` a
                                  potential threat to the long - term viability of Retrovir
    17  0
    18  if
    19  the
           coref: IDENT        16    19-20  the product
    20  product
           sense: product-n.1
    21  were
           sense: be-v.1
           prop:  be.03
            v          * -> 21:0, were
    22  *-2
    23  to
    24  be
    25  successfully
    26  developed
           sense: develop-v.1
           prop:  develop.02
            v          * -> 26:0, developed
            ARG1       * -> 27:0, *-1 -> 22:0, *-2 -> 19:1, the product
            ARGM-MNR   * -> 25:1, successfully
            LINK-PCR   * -> 19:1, the product
                       * -> 27:0, *-1 -> 22:0, *-2 -> 19:1, the product
    27  *-1
    28  it
           coref: IDENT        16    28-28  it
    29  would
    30  represent
           sense: represent-v.1
           prop:  represent.01
            v          * -> 30:0, represent
            ARGM-ADV   * -> 18:1, if the product were *-2 to be successfully developed *-1
            ARG0       * -> 28:1, it
            ARGM-MOD   * -> 29:0, would
            ARG1       * -> 32:2, a potential threat to the long - term viability of Retrovir
    31  ``
    32  a
    33  potential
    34  threat
           sense: threat-n.1
    35  to
    36  the
    37  long
    38  -
    39  term
    40  viability
    41  of
    42  Retrovir
           coref: IDENT        38    42-42  Retrovir
           name:  PRODUCT            42-42  Retrovir
    43  .


========================================================================================================================
Coreference chains for section 0:
---------------------------------

    Chain 21 (IDENT)
               0.0-2      Two Japanese scientists
               0.5-5      they
               4.1-3      the researchers themselves
               4.6-6      they
               4.14-14    they
               7.0-11     Dr. Yonehara and his partner , Nobuyuki Kobayashi of Yamaguchi University ,
               7.14-14    their
               8.14-15    the researchers
               10.0-1     The two
               10.4-4     they
               11.0-0     They
               11.3-3     they
               12.16-16   they
               18.1-4     he and Dr. Yonehara
               19.1-1     Our
               20.1-1     We
               20.8-8     our

    Chain 30 (IDENT)
               0.3-3      said
               13.0-1     The announcement

    Chain 22 (IDENT)
               0.6-6      discovered
               26.8-14    the discovery of the antibody in Japan

    Chain 16 (IDENT)
               0.7-28     an antibody that , in laboratory test - tube experiments , *T*-1 kills AIDS - infected cells
                          while *PRO*-2 preserving healthy cells
               5.17-22    the antibody 0 he discovered *T*-2
               6.0-1      The antibody
               7.18-19    the antibody
               8.6-6      it
               14.36-36   its
               15.23-24   the antibody
               17.7-8     the antibody
               19.1-2     Our antibody
               19.14-14   it
               20.8-9     our antibody
               26.11-12   the antibody
               27.19-20   the product
               27.28-28   it

    Chain 28 (IDENT)
               0.12-16    laboratory test - tube experiments
               7.14-15    their experiments
               8.3-4      the experiments

    Chain 20 (IDENT)
               0.20-22    AIDS - infected
               1.16-19    acquired immune deficiency syndrome
               2.22-22    AIDS
               2.27-27    it
               7.28-30    AIDS - infected
               12.5-5     AIDS
               14.22-24   AIDS - research
               21.0-0     AIDS
               21.19-20   the virus
               24.13-14   the disease

    Chain 40 (IDENT)
               1.1-2      further experiments
               1.6-7      the work

    Chain 35 (IDENT)
               2.0-11     The drug AZT , the only treatment currently on the market ,
               24.0-0     AZT
               25.10-11   the drug

    Chain 23 (APPOS)
        HEAD   2.0-2      The drug AZT
        ATTRIB 2.4-10     the only treatment currently on the market

    Chain 24 (IDENT)
               3.21-21    yesterday
               13.16-16   yesterday

    Chain 32 (IDENT)
               3.29-30    the results
               16.1-2     The results

    Chain 18 (IDENT)
               5.0-14     Shin Yonehara , a research scientist at the Tokyo Metropolitan Institute of Medical Science ,
               5.20-20    he
               7.0-1      Dr. Yonehara
               7.3-3      his
               18.3-4     Dr. Yonehara
               19.24-25   Dr. Yonehara

    Chain 25 (APPOS)
        HEAD   5.0-1      Shin Yonehara
        ATTRIB 5.3-13     a research scientist at the Tokyo Metropolitan Institute of Medical Science

    Chain 26 (IDENT)
               5.42-44    an infected cell
               6.4-5      the cell

    Chain 13 (IDENT)
               7.3-11     his partner , Nobuyuki Kobayashi of Yamaguchi University ,
               17.0-1     Dr. Kobayashi
               17.4-4     he
               18.1-1     he

    Chain 27 (APPOS)
        ATTRIB 7.3-4      his partner
        HEAD   7.6-10     Nobuyuki Kobayashi of Yamaguchi University

    Chain 29 (IDENT)
               12.0-0     Japan
               12.13-14   that country
               14.10-11   Japan 's
               14.19-21   the government 's
               21.9-9     Japan
               21.11-12   the government
               22.12-12   Japan
               26.14-14   Japan

    Chain 14 (IDENT)
               14.1-26    Takashi Kitamura , director of the biology department at Japan 's National Institute of Health
                          and secretary of the government 's AIDS - research center ,
               14.30-30   I
               15.0-0     He
               22.0-1     Dr. Kitamura
               23.0-0     He

    Chain 31 (APPOS)
        HEAD   14.1-2     Takashi Kitamura
        ATTRIB 14.4-25    director of the biology department at Japan 's National Institute of Health and secretary of
                          the government 's AIDS - research center

    Chain 33 (APPOS)
        HEAD   16.13-14   Mitsuru Miyata
        ATTRIB 16.16-25   editor of Nikkei Biotechnology , a leading Japanese industry newsletter

    Chain 34 (APPOS)
        HEAD   16.18-19   Nikkei Biotechnology
        ATTRIB 16.21-25   a leading Japanese industry newsletter

    Chain 36 (APPOS)
        HEAD   25.0-1     Wellcome PLC
        ATTRIB 25.3-7     a major British pharmaceutical maker

    Chain 39 (IDENT)
               25.0-8     Wellcome PLC , a major British pharmaceutical maker ,
               26.1-1     Wellcome

    Chain 38 (IDENT)
               25.13-15   the name Retrovir
               27.42-42   Retrovir

    Chain 37 (APPOS)
        HEAD   27.1-2     Andrew Porter
        ATTRIB 27.4-14    a drug - industry analyst at Nikko Securities Co. in London
